GSK
GSK | NYSE
$50.68
-$0.40 (-0.78%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 3.39B | 3.69B | 3.74B | 3.72B | 5.79B | 8.6B |
Short-Term Investments | 8.98M | 21M | 2.86B | 4.15B | 82.62M | 106.62M |
Long-Term Investments | 1.12B | 1.21B | 2.73B | -2.61B | 4.29B | 4.83B |
Other Long-Term Assets | 2.14B | 1.93B | 808.22M | 5.35B | 1B | 1.28B |
Receivables | 7.75B | 6B | 9.44B | 6.22B | 10.88B | 9.93B |
Inventory | 5.91B | 5.67B | 7.01B | 5.15B | 7.83B | 8.2B |
Other Current Assets | 420.26M | 1.23B | 262.61M | 1.1B | 284.44M | 352.67M |
Total Current Assets | 17.48B | 17B | 23.77B | 20.77B | 25.29B | 27.68B |
Property-Plant & Equipment | 10.03B | 10.07B | 12.69B | 9.62B | 14.45B | 15.04B |
Goodwill & Intangibles | 23.72B | 22.5B | 27.51B | 21.36B | 55.03B | 55.25B |
Total Long-Term Assets | 43.53B | 42.47B | 51.45B | 39.38B | 81.85B | 82.27B |
Total Assets | 61.01B | 59.46B | 75.22B | 60.15B | 107.14B | 109.95B |
Account Payables | 15.35B | 3.46B | 4.74B | 3.87B | 6.14B | 5.96B |
Deferred Revenue | n/a | n/a | 283.01M | n/a | 415.82M | 493.47M |
Short-Term Debt | 3.01B | 2.18B | 3.59B | 3.79B | 4.88B | 5.09B |
Other Current Liabilities | 2.5B | 14.76B | 15.25B | 14.1B | 17.97B | 16.03B |
Total Current Liabilities | 21.35B | 21.7B | 26.86B | 22.81B | 32.06B | 30.28B |
Long-Term Debt | 14.68B | 13.7B | 18.04B | 16.19B | 26.76B | 30.81B |
Other Long-Term Liabilities | 8.69B | 9.5B | 11.95B | 9.83B | 13.38B | 14.26B |
Total Long-Term Liabilities | 23.66B | 24.68B | 32.05B | 27.24B | 46.17B | 51.23B |
Total Liabilities | 45.02B | 46.38B | 58.91B | 50.05B | 78.23B | 81.5B |
Total Debt | 17.69B | 16.99B | 22.97B | 20.99B | 32.74B | 37.11B |
Book Value | 15.99B | 13.09B | 16.31B | 10.1B | 28.91B | 28.44B |
Book Value Per Share | 7.77 | 6.32 | 7.94 | 4.94 | 17.83 | 14.11 |
Common Stock | 1.35B | 1.35B | 1.72B | 1.35B | 1.82B | 1.84B |
Retained Earnings | 10.19B | 7.8B | 9.23B | 4.36B | 13.26B | 11.76B |
Comprehensive Income | n/a | n/a | 2.04B | n/a | 869.56M | 2.12B |
Shareholders Equity | 16.35B | 13.67B | 17.01B | 10.6B | 20.39B | 19.94B |
Total Investments | 1.13B | 1.23B | 5.59B | 1.54B | 4.37B | 4.93B |
Add to Watchlist
Select watchlists to add or remove GSK